ScottD.PendergastMD

PubMed

• 7 citations
  Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular d...
  Joseph M Coney, Ryan Zubricky, Samriddhi Buxy Sinha, Nina Sonbolian, Lujia Zhou, Thomas P Hull, Shawn A Lewis, David G Miller, Michael A Novak, Scott D Pendergast, Han...> ;International Journal of Retina and Vitreous. 2023 Feb 1
• One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents.
  Coney, J., McCoy, J., Buxy Sinha, S., Sonbolian, N., Zhou, L., Hull, T., Lewis, S., Miller, D., Novak, M., Pendergast, S., Pham, H., Platt, S., Rao, L., Schartman, J.,...> ;Clinical Ophthalmology. 2023 Jan 1
• 34 citations
  Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17
  Jeannette J. Yu, Elvira Agrón, Traci E. Clemons, Amitha Domalpally, Freekje van Asten, Tiarnan D L Keenan, Catherine A Cukras, Emily Y. Chew, Frederick L. Ferris, John...> ;Ophthalmology. 2019 Feb 1
• 113 citations
  Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.
  Tiarnan D L Keenan, Elvira Agrón, Amitha Domalpally, Traci E. Clemons, Freekje van Asten, Wai T. Wong, Ronald G. Danis, Srinivas R. Sadda, Philip J. Rosenfeld, Michael...> ;Ophthalmology. 2018 Dec 1
• 122 citations
  Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials
  Alex S. Willoughby, Gui-Shuang Ying, Cynthia A. Toth, Maureen G. Maguire, Russell Burns, Juan E. Grunwald, Ebenezer Daniel, Glenn J. Jaffe, David F. Williams, Sara Bea...> ;Ophthalmology. 2015 Sep 1
• 5 citations
  The effects of scleral buckling on young rabbit eyes.
  Andrew A. Moshfeghi, Scott D. Pendergast, Michael Hartzer, Philip J. Ferrone> ;Archives of Ophthalmology. 2004 Apr 1
• 34 citations
  Laser treatment in fellow eyes with large drusen: Updated findings from a pilot randomized clinical trial
  Maureen G. Maguire, Paul Sternberg, Thomas M. Aaberg, Daniel F. Martin, David A. Saperstein, Maureen Hyatt, James Gilman, Ray Swords, Gabriela Nemes, Lawrence J. Singe...> ;Ophthalmology. 2003 May 1
• 159 citations
  Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid.
  Scott D. Pendergast, Tarek S Hassan, George A. Williams, Morton S. Cox, Raymond R. Margherio, Philip J. Ferrone, Bruce R. Garretson, Michael T. Trese> ;American Journal of Ophthalmology. 2000 Aug 1
• 26 citations
  Absence of herpesvirus DNA by polymerase chain reaction in ocular fluids obtained from immunocompetent patients.
  Scott D. Pendergast, Jane C. Werner, Ann M. Drevon, Danny L. Wiedbrauk> ;Retina. 2000 Jan 1
• 41 citations
  Vitrectomy for chronic pseudophakic cystoid macular edema.
  Scott D. Pendergast, Raymond R. Margherio, George A. Williams, Morton S. Cox> ;American Journal of Ophthalmology. 1999 Sep 1
• 120 citations
  Familial exudative vitreoretinopathy: Results of surgical management
  Scott D. Pendergast, Michael T. Trese> ;Ophthalmology. 1998 Jun 1
• 38 citations
  Vitrectomy for diabetic macular edema associated with a taut premacular posterior hyaloid.
  Scott D. Pendergast> ;Current Opinion in Ophthalmology. 1998 Jun 1
• 16 citations
  Study of the Norrie Disease Gene in 2 Patients With Bilateral Persistent Hyperplastic Primary Vitreous
  Scott D. Pendergast, Michael T. Trese, Xuyang Liu, Barkur S. Shastry> ;Archives of Ophthalmology. 1998 Mar 1
• 7 citations
  Double Choroidal Malignant Melanoma in an Eye With Apparent Clinical RegressionDavid apple and milton boniuk, editors
  David E. E. Holck, Jonathan J. Dutton, Scott D. Pendergast, Gordon K. Klintworth> ;Survey of Ophthalmology. 1998 Mar 1
• 82 citations
  Vitrectomy for Retained Lens Fragments after Phacoemulsification
  Raymond R. Margherio, Alan R. Margherio, Scott D. Pendergast, George A. Williams, B. R. Garretson, Leroy E. Strong, Michael T. Trese, Morton S. Cox, Tarek S Hassan> ;Ophthalmology. 1997 Sep 1
• 117 citations
  Identification of Missense Mutations in the Norrie Disease Gene Associated With Advanced Retinopathy of Prematurity
  Barkur S. Shastry, Scott D. Pendergast, Michael Hartzer, Xuyang Liu, Michael T. Trese> ;Archives of Ophthalmology. 1997 May 1
• 10 citations
  Ocular findings in cutis marmorata telangiectatica congenita. Bilateral exudative vitreoretinopathy.
  Scott D. Pendergast, Michael T. Trese, Barkur S. Shastry> ;Retina. 1997 Jan 1
• 81 citations
  Visual field loss after macular hole surgery
  Scott D. Pendergast, Brooks W. McCuen> ;Ophthalmology. 1996 Jul 1
• 7 citations
  Retinal toxic effects following inadvertent intraocular injection of Celestone Soluspan.
  Scott D. Pendergast, Dean Eliott, Robert Machemer> ;Archives of Ophthalmology. 1995 Oct 1
• 10 citations
  Removal of optic disc stalks during diabetic vitrectomy.
  Scott D. Pendergast, Daniel F. Martin, Alan D. Proia, Glenn J. Jaffe, Brooks W. McCuen> ;Retina. 1995 Jan 1
• Reproducibility of optic nerve head topographic measurements with the glaucoma-scope.
  Pendergast, S. D., Shields, M. B.> ;J Glaucoma. 1995 Jun 01
• The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues.
  Colgan, T. J., Pendergast, S., LeBlanc, M.> ;Hum Pathol. 1993 Oct
• Join now to see all

Journal Articles

• Subretinal hyperreflective material in the Comparison of Age-Related Macular Degeneration Treatments Trials  
  Willoughby AS, Ying GS, Toth CA, Maguire MG, Burns RE, Grunwald JE, Daniel E, Jaffe GJ; Comparison of Age-Related Macular Degeneration Treatments Trials Research Group, Ophthalmology, 1/1/2015
• Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)  
  Altaweel MM, Daniel E, Martin DF, Mittra RA, Grunwald JE, Lai MM, Melamud A, et al; Maguire MG; Comparison of Age-related Macular Degeneration Treatments Trials (CATT)..., Ophthalmology, 1/1/2015
• Ciliary neurotrophic factor (CNTF) for macular telangiectasia Type 2 (MacTel): Results from a phase I safety trial  
  Chew EY, Clemons TE, Peto T, Sallo FB, Ingerman A, Tao W, Singerman L, Schwartz SD, Peachey NS, Bird AC; MacTel-CNTF Research Group, Am J Ophthalmol, 1/1/2015
• Effect of pegaptanib sodium 03 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from VISION study  
  Boyer DS, Goldbaum M, Leys AM, Starita C; for the V.I.S.I.O.N. Study Group, Br J Ophthalmol, 1/1/2014
• VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (...  
  Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Maguire MG, Martin DF; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, JAMA Ophthalmol, 1/1/2014
• Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)  
  Kim BJ, Ying GS, Huang J, Levy NE, Maguire MG; CATT Research Group, Am J Ophthalmol, 1/1/2014
• Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions  
  Nathan DM, Bayless M, Cleary P, et al; DCCT/EDIC Research Group, Diabetes, 1/1/2013
• Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials  
  Maguire MG, Daniel E, Shah AR, Grunwald JE, et al; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT Research Group), Ophthalmology, 1/1/2013
• Nine loci for ocular axial length identified through genome-wide association studies, including shared loci with refractive error  
  Cheng CY, Schache M, Ikram MK, et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions, and Complications Research Group, Am J Hum Genet, 1/1/2013
• The association of skin intrinsic fluorescence with type 1 diabetes complications in the DCCT/EDIC study  
  Orchard TJ, Lyons TJ, Cleary PA, et al; DCCT/EDIC Research Group, Diabetes Care, 1/1/2013
• The long-term effects of type 1 diabetes treatment and complications on health-related quality of life: a 23-year follow-up of the Diabetes Control and Complications/E...  
  Jacobson AM, Braffett BH, Cleary PA, Gubitosi-Klug RA, Larkin ME; DCCT/EDIC Research Group, Diabetes Care, 1/1/2013
• Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia  
  Verhoeven VJ, Hysi PG, Wojciechowski R,et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Nat Genet, 1/1/2013
• Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials  
  Jaffe GJ, Martin DF, Toth CA,et al; Comparison of Age-related Macular Degeneration Treatments Trials Research Group, Ophthalmology, 1/1/2013
• Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2)  
  Danis RP, Domalpally A, Chew EY, et al; AREDS2 Study Group, Invest Ophthalmol Vis Sci, 1/1/2013
• Is indocyanine green angiography useful for the diagnosis of macular telangiectasia type 2?  
  Niskopoulou M, Balaskas K, Leung I, Sallo FB, Clemons TE, Bird AC, Peto T; MacTel Study Group, Br J Ophthalmol, 1/1/2013
• Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT)  
  Hagstrom SA, Ying GS, Pauer GJ, et al; Comparison of AMD Treatments Trials Research Group, Ophthalmology, 1/1/2013
• Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration  
  Ying GS, Huang J, Maguire MG, et al; omparison of Age-related Macular Degeneration Treatments Trials Research Group, Ophthalmology, 1/1/2013
• Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results  
  Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford..., Ophthalmology, 1/1/2012
• Ranibizumab and bevacizumab for neovascular age-related macular degeneration  
  CATT Research Group, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ, N Engl J Med, 1/19/2011
• Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes  
  DCCT/EDIC Research Group, de Boer IH, Sun W, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Zinman B, N Engl J Med, 1/1/2011
• Retinal crystals in type 2 idiopathic macular telangiectasia  
  Sallo FB, Leung I, Chung M, Wolf-Schnurrbusch UE, Dubra A, Williams DR, Clemons T, Pauleikhoff D, Bird AC, Peto T; MacTel Study Group, Ophthalmology, 1/1/2011
• Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results  
  Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM; Ozurdex GENEVA Study Group, Li J, Ophthalmology, 1/1/2011
• Incidences of neovascular events in eyes with retinal vein occlusion  
  Chan CK, Ip MS, Vanveldhuisen PC, Oden NL, Scott IU, Tolentino MJ, Blodi BA; SCORE Study Investigator Group, Ophthalmology, 1/1/2011
• Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration  
  Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, Jakobsdottir J, Tosakulwong N, Pericak-Vance MA, Campochiaro PA, Klein ML, Tan PL, Conley YP, Kanda A, Kopplin ..., Proc Natl Acad Sci U S A, 1/20/2010
• Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study  
  Friberg TR, Tolentino M; LEVEL Study Group, Weber P, Patel S, Campbell S, Goldbaum M, Br J Ophthalmol, 1/1/2010
• Join now to see all

Books/Book Chapters

• Current Ocular Therapy 
  Chapter: Choroidal ruptures. 
  Page 313 - 314Pendergast SD, Singerman LJEditors: Fraunfelder FT, Roy H.WB Saunders Company, Philadelphia2000
• Current Techniques in Ophthalmic Laser Surgery 
  Chapter: Laser management of less common macular diseases. 
  Page 111 - 128Niffenegger JH, Pendergast SD, Singerman LJEditors: Singerman LJ, Coscas G.Current Medicine, Philadelphia1999
• Current Techniques in Ophthalmic Laser Surgery 
  Chapter: Photocoagulation of other causes of choroidal neovascularization. 
  Page 91 - 110Niffenegger JH, Pendergast SD, Singerman LJEditors: Singerman LJ, Coscas G.Current Medicine, Philadelphia1999
• Current Techniques in Ophthalmic Laser Surgery 
  Chapter: Laser management of branch and central retinal vein occlusions. 
  Page 67 - 76Zegarra H, Finkelstein D, Singerman LJ, Niffenegger JH, Pendergast SDEditors: Singerman LJ, Coscas G.Current Medicine, Philadelphia1999
• Current Techniques in Ophthalmic Laser Surgery 
  Chapter: Lasers in the treatment of proliferative retinopathies. 
  Page 35 - 53Pendergast SD, Singerman LJ, Niffenegger JH, Zegarra HEditors: Singerman LJ, Coscas G.Current Medicine, Philadelphia1999
• Current Techniques in Ophthalmic Laser Surgery 
  Chapter: Lasers in vitreous surgery. 
  Page 153 - 163Pendergast SD, Zakov ZN, Novak MAEditors: Singerman LJ, Coscas G.Current Medicine, Philadelphia1999
• Macular Hole: Pathogenesis, Diagnosis and Treatment 
  Chapter: Complications in macular hole surgery. 
  Page 155 - 168Pendergast SD, Williams GAEditors: McCuen BW, Madreperla SA.Butterworth Heineman, Boston1998
• Vitreo-Retinal and Uveitis Update. Proceedings of the New Orleans Academy of Ophthalmology Symposium 
  Chapter: Central retinal vein occlusion. 
  Page 259 - 267Zegarra H, Singerman LJ, Pendergast SDEditors: Saer JB.Kugler Publications, The Hague1998
• Vitreo-Retinal and Uveitis Update. Proceedings of the New Orleans Academy of Ophthalmology Symposium 
  Chapter: Laser treatment of proliferative retinopathies. 
  Page 97 - 121Pendergast SD, Singerman LJ, Niffenegger JH, Zegarra HEditors: Saer JB.Kugler Publications, The Hague1998
• Glaucoma Update V 
  Chapter: Reproducibility of optic nerve head topographical measurements with the Glaucoma-Scope. 
  Pendergast SD, Shields MBEditors: Krieglstein GK.Kaden, Heidelberg1995
• Join now to see all

Abstracts/Posters

• Identification of a missense mutation in the Norrie's disease gene associated with advanced retinopathy of prematurity.
  Pendergast SD, Shastry BS, Hartzer MK, Trese MT, Research Forum, William Beaumont Hospital, 1/5/1996
• Effect of intravitreal suramin on a rabbit model of proliferative vitreoretinopathy.
  T. Hassan, Pendergast SD, Hartzer M, Cheng M, Invest Ophthalmol Vis Sci, 1/1/1996
• Fluid-gas exchange following intravitreal plasmin injection in a rabbit model.
  Pendergast SD, Hartzer M, Dailey W, Williams GA, M Cheng M, Trese MT, Invest Ophthalmol Vis Sci, 1/1/1996
• Surgical management of familial exudative vitreoretinopathy.
  Pendergast SD, Trese MT, Ophthalmology, 1/1/1996
• Visual field loss following macular hole surgery.
  Pendergast SD, McCuen BW II, Ophthalmology, 1/1/1995
• ERG changes in patients with long-standing diabetes and early diabetic retinopathy.
  Wu G, Pendergast SD, Roh S-Y, Gutierrez J, Brodie SE, ARVO Meeting, Sarasota, FL, 1/5/1991
• Practice patterns in the treatment of diabetic retinopathy in a referral population.
  Charles JB, Wu G, Roh S-Y, Gutierrez J, Pendergast SD, Weiter JJ, Invest Ophthalmol Vis Sci, 1/1/1991
• ERG changes in patients with long-standing diabetes mellitus and early diabetic retinopathy.
  Wu G, Pendergast SD, Roh S-Y, Gutierrez J, Brodie SE, Invest Ophthalmol Vis Sci, 1/1/1991
• Join now to see all

Lectures

• Clinical update on Fovista. 
  Warren, OH - 1/1/2015
• Retinal emergencies. 
  Warren, OH - 1/10/2013
• Evaluation and treatment of retinal vein occlusion. 
  Beachwood, OH - 1/25/2010
• Interesting retinal vascular cases. 
  Beachwood, OH - 1/21/2008
• Update on Lucentis and Avastin in the treatment of neovascular age-related macular degeneration. 
  Beachwood, OH - 1/15/2007
• Role of anti-VEGF agents in retinal disorders. 
  Youngstown, OH - 1/5/2007
• Update on anti-VEGF therapies in age-related macular degeneration. 
  Beachwood, OH - 1/25/2006
• The role of anti-VEGF therapy for the treatment of exudative AMD. 
  Cleveland, OH - 1/15/2006
• Retinal degenerations. 
  Beachwood, OH - 1/9/2006
• Hereditary vitreoretinal degenerations. 
  1/1/2006
• Macugen for AMD: VISION study results and exploratory analysis. 
  Albuquerque, NM - 1/20/2005
• Macugen for age-related macular degeneration: two year results. 
  Beachwood, OH - 1/15/2005
• Update on Visudyne therapy. 
  Boardman, OH - 1/14/2005
• VEGF and its role in AMD: Implications for therapeutics. 
  Albany, NY - 1/11/2005
• The genetics of macular degeneration. 
  Solon, OH - 1/4/2005
• Vascular endothelial growth factor: its role in ocular disease and implications for therapeutic intervention. 
  1/2/2005
• Management of vasoproliferative and neovascular ocular disorder: case studies. 
  Beachwood, OH - 1/19/2004
• The role of vascular endothelial growth factor in ocular disease. 
  Columbus, OH - 1/15/2004
• Implantable Miniature Telescope (IMT™): an update. 
  Independence, OH - 1/10/2004
• Intravitreal steroid injection for refractory cystoid macular edema. 
  Porto Carras, Chalkidiki, Greece - 1/9/2004
• Intravitreal Kenalog injection for cystoid macular edema. 
  Youngstown, OH - 1/6/2004
• New treatments for diabetic macular edema. 
  Beachwood, OH - 1/1/2003
• Update on diabetic retinopathy. 
  Lorain, OH - 1/15/2002
• Intravitreal injection of anti-angiogenic agents for age-related macular degeneration. 
  Lorain, OH - 1/1/2002
• New horizons in the treatment of diabetic retinopathy. 
  Richfield, OH - 1/1/1999
• Join now to see all